Healthcare provider profile · identity verified

Michael E Glickman, MD

Internal Medicine · MOUNT PROSPECT, IL · NPI 1154347128

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	169
Levothyroxine Sodium	Levothyroxine Sodium	282	67
Lisinopril	Lisinopril	230	51
Amlodipine Besylate	Amlodipine Besylate	224	67
Simvastatin	Simvastatin	197	43
Gabapentin	Gabapentin	176	36
Escitalopram Oxalate	Escitalopram Oxalate	172	45
Pantoprazole Sodium	Pantoprazole Sodium	165	46
Sertraline Hcl	Sertraline Hcl	157	29
Losartan Potassium	Losartan Potassium	153	42
Omeprazole	Omeprazole	140	40
Alprazolam	Alprazolam	137	44
Metoprolol Succinate	Metoprolol Succinate	135	41
Lorazepam	Lorazepam	123	19
Hydrochlorothiazide	Hydrochlorothiazide	113	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	104	25
Allopurinol	Allopurinol	100	28
Glimepiride	Glimepiride	98	21
Eliquis	Apixaban	96	24
Meloxicam	Meloxicam	95	28
Fluticasone Propionate	Fluticasone Propionate	94	40
Zolpidem Tartrate	Zolpidem Tartrate	94	21
Rosuvastatin Calcium	Rosuvastatin Calcium	87	29
Trazodone Hcl	Trazodone Hcl	87	20
Metformin Hcl Er	Metformin Hcl	81	24
Tramadol Hcl	Tramadol Hcl	81	20
Clonazepam	Clonazepam	74	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	21
Metoprolol Tartrate	Metoprolol Tartrate	67	20
Furosemide	Furosemide	65	25
Tamsulosin Hcl	Tamsulosin Hcl	64	20
Memantine Hcl	Memantine Hcl	61	suppressed
Metformin Hcl	Metformin Hcl	58	19
Venlafaxine Hcl Er	Venlafaxine Hcl	56	15
Potassium Chloride	Potassium Chloride	53	14
Carvedilol	Carvedilol	51	14
Clopidogrel	Clopidogrel Bisulfate	51	15
Diazepam	Diazepam	51	15
Jardiance	Empagliflozin	48	suppressed
Duloxetine Hcl	Duloxetine Hcl	47	13
Pregabalin	Pregabalin	42	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	23
Ozempic	Semaglutide	40	suppressed
Finasteride	Finasteride	38	suppressed
Irbesartan	Irbesartan	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	11
Montelukast Sodium	Montelukast Sodium	37	suppressed
Ipratropium Bromide	Ipratropium Bromide	36	15
Mounjaro	Tirzepatide	35	suppressed
Nifedipine Er	Nifedipine	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Galantamine Er	Galantamine Hbr	34	suppressed
Prednisone	Prednisone	34	15
Spironolactone	Spironolactone	34	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	11
Warfarin Sodium	Warfarin Sodium	32	suppressed
Celecoxib	Celecoxib	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Atenolol	Atenolol	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	16
Mirtazapine	Mirtazapine	28	suppressed
Lamotrigine	Lamotrigine	27	suppressed
Glipizide	Glipizide	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Valsartan	Valsartan	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Risedronate Sodium	Risedronate Sodium	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Colchicine	Colchicine	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Methylprednisolone	Methylprednisolone	19	17
Novolog Flexpen	Insulin Aspart	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Naproxen	Naproxen	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Azithromycin	Azithromycin	15	12
Carvedilol Er	Carvedilol Phosphate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Clonidine	Clonidine	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Nucynta	Tapentadol Hcl	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Baclofen	Baclofen	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ramipril	Ramipril	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Eszopiclone	Eszopiclone	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Temazepam	Temazepam	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error